Skip to main content

Leonteq Securities AG

Broker-Dealer

Position in NVO — Novo Nordisk A S

CIK 1535950 ZURICH, V8

Position in NVO

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$1,380,480
-$4,251,200 QoQ
Shares Held
28,796
-81.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#451
of 1,348 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Jun 30, 2026
CallValue
$1,054,680
CallShares
22,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Leonteq Securities AG holds $17,608,542 across 13 Drug Manufacturers - General names. NVO ranks #7 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
28,796 $1,380,480

All Filings in NVO

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,054,680 22,000
2026-06-30 $1,380,480 28,796
2026-03-31 $5,631,680 153,243
2026-03-31 $11,025,000 300,000
2026-03-31 $73,500 2,000
2025-12-31 $101,760 2,000
2025-09-30 $5,549,000 100,000
2025-09-30 $9,970,443 179,680
2025-09-30 $110,980 2,000
2025-06-30 $138,040 2,000
2025-06-30 $22,098,823 320,180
2025-03-31 $83,328 1,200
2025-03-31 $8,261,346 118,971
2024-12-31 $10,407,473 120,989
2024-09-30 $4,149,232 34,847
2024-06-30 $2,182,780 15,292
2024-03-31 $1,661,496 12,940
2023-12-31 $357,419 3,455
2023-09-30 $246,447 2,710
2023-06-30 $122,181 755
2022-12-31 $135 1
2022-09-30 $99 1
2022-06-30 $111 1
2022-03-31 $111 1
2021-12-31 $44,912 401
2021-09-30 $4,896 51
2021-06-30 $13,235 158
2021-03-31 $34,653 514
2020-12-31 $878,154 12,572